Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
| Autor: | Klang, Shmuel H., Hammerman, Ariel, Liebermann, Nicky, Efrat, Noa, Doberne, Julie, Hornberger, John |
|---|---|
| Zdroj: | In Value in Health 2010 13(4):381-387 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect